Schedule 13D ownership disclosure

ZIVO BIOSCIENCE

Common Stock, par value $.001 per share · CUSIP: 98978N101

Event date: 2024-12-26

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Mark E. StromeReported CIK 0000919484

    Shares: 442,854.00 · Class: 12.20%

  • Strome Group, Inc.

    Shares: 222,505.00 · Class: 6.13%

  • Strome Investment Management, LP

    Shares: 222,505.00 · Class: 6.13%

  • Strome Mezzanine Fund, LPReported CIK 0001713153

    Shares: 45,064.00 · Class: 1.24%

  • Strome Mezzanine Fund II, LP

    Shares: 165,000.00 · Class: 4.55%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-25-001739
Form type
SCHEDULE 13D/A
Filer
STROME MARK E
CIK
CIK 919484
Filed
Jan 07, 2025
Reporting period
Dec 26, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub